Skip to main content
Caplight Logo









ExoCoBio

ExoCoBio

Private
SeoulHealthcare & Life Scienceshttp://exocobio.com/

Last Round

Series C

Aug 25, 2020

Total Funding Raised

$47M

Company Overview

ExoCoBio is a biotechnology company that develops exosome-based biopharmaceuticals and regenerative aesthetic products for skin and hair.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Fashion & Beauty, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

exosome therapyregenerative aestheticsstem cell exosomescosmeceuticalsmedical aestheticsskin rejuvenationhair restorationanti-aging treatmentExoSCRTmedical grade skincareASCE+exosome isolationK-beautyGMP manufacturinglyophilized exosomesbiopharmaceuticals

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ExoCoBio Comparables

Compare ExoCoBio with similar companies based on industry and business-model similarity.

ExoCoBio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Rion Aesthetics
84%
Primoris International Co., Ltd.
81%
Kimera Labs
80%

ExoCoBio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CAug 25, 2020
Series BSep 12, 2018
Series AMay 4, 2017

ExoCoBio Investors

Notable investors and investment history

ExoCoBio investors
InvestorRounds
ID VenturesSeries A
InterVestSeries B
KDB Capital CorpSeries B
K2 Investment PartnersSeries C, Series B
Csquared Global Asset ManagementSeries B
Focus Assets ManagementSeries C
TS InvestmentSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 22, 2026

    Grew 23% QoQ, from 22 to 27 employees.

  • Jan 26, 2026

    Monthly visitors increased 148% MoM, reaching 38.8K.

ExoCoBio Filings

Explore SEC and related filing metadata, where available.

ExoCoBio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about ExoCoBio's valuation, stock price, and market status.

Is ExoCoBio a public or private company?

ExoCoBio is a private company.

What is the current stock price of ExoCoBio?

ExoCoBio is a private company with no public stock price. No recent secondary market data is available.

How much is ExoCoBio worth (valuation)?

Valuation information for ExoCoBio is not publicly available.

Can I buy ExoCoBio stock?

ExoCoBio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was ExoCoBio's last funding round?

ExoCoBio's most recent funding round was Series C on August 25, 2020.

Who are the main investors in ExoCoBio?

Key investors in ExoCoBio include InterVest, KDB Capital Corp, K2 Investment Partners, Csquared Global Asset Management, Focus Assets Management.

Will ExoCoBio IPO soon?

No public IPO plans have been announced for ExoCoBio.

How can I track ExoCoBio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ExoCoBio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSeoul
Employee Range29
Year Founded2017
Last FundingAug 25, 2020

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?